| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine kinase activity | 6.46e-07 | 46 | 30 | 4 | GO:0004715 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | 1.04e-06 | 372 | 30 | 7 | GO:0061630 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 1.62e-06 | 398 | 30 | 7 | GO:0061659 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 2.32e-06 | 145 | 30 | 5 | GO:0004713 | |
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | 5.08e-06 | 473 | 30 | 7 | GO:0004842 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | 8.53e-06 | 512 | 30 | 7 | GO:0019787 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | 1.09e-05 | 532 | 30 | 7 | GO:0016755 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 1.20e-04 | 775 | 30 | 7 | GO:0016746 | |
| GeneOntologyMolecularFunction | ubiquitin-ubiquitin ligase activity | 1.96e-04 | 14 | 30 | 2 | GO:0034450 | |
| GeneOntologyMolecularFunction | phospholipase activator activity | 5.41e-04 | 23 | 30 | 2 | GO:0016004 | |
| GeneOntologyMolecularFunction | gap junction channel activity | 6.41e-04 | 25 | 30 | 2 | GO:0005243 | |
| GeneOntologyMolecularFunction | lipase activator activity | 7.48e-04 | 27 | 30 | 2 | GO:0060229 | |
| GeneOntologyMolecularFunction | ephrin receptor binding | 1.05e-03 | 32 | 30 | 2 | GO:0046875 | |
| GeneOntologyMolecularFunction | phospholipase binding | 1.05e-03 | 32 | 30 | 2 | GO:0043274 | |
| GeneOntologyMolecularFunction | wide pore channel activity | 1.41e-03 | 37 | 30 | 2 | GO:0022829 | |
| GeneOntologyMolecularFunction | protein kinase activity | 1.84e-03 | 600 | 30 | 5 | GO:0004672 | |
| GeneOntologyMolecularFunction | kinase binding | 2.80e-03 | 969 | 30 | 6 | GO:0019900 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 3.79e-03 | 709 | 30 | 5 | GO:0016773 | |
| GeneOntologyMolecularFunction | kinase activity | 5.21e-03 | 764 | 30 | 5 | GO:0016301 | |
| GeneOntologyBiologicalProcess | innate immune response | SRMS TRIM49 PELI1 TRAF6 FYN TRIM49B IFIT1 ZAP70 TRIM51G SRC TRIM49C | 1.88e-07 | 1092 | 30 | 11 | GO:0045087 |
| GeneOntologyBiologicalProcess | defense response to symbiont | SRMS TRIM49 PELI1 TRAF6 FYN TRIM49B IFIT1 ZAP70 TRIM51G SRC TRIM49C | 9.62e-07 | 1286 | 30 | 11 | GO:0140546 |
| GeneOntologyBiologicalProcess | defense response to other organism | SRMS TRIM49 PELI1 TRAF6 FYN TRIM49B IFIT1 ZAP70 TRIM51G SRC TRIM49C | 2.33e-06 | 1407 | 30 | 11 | GO:0098542 |
| GeneOntologyBiologicalProcess | stimulatory C-type lectin receptor signaling pathway | 4.82e-06 | 23 | 30 | 3 | GO:0002223 | |
| GeneOntologyBiologicalProcess | cellular response to lectin | 4.82e-06 | 23 | 30 | 3 | GO:1990858 | |
| GeneOntologyBiologicalProcess | response to lectin | 4.82e-06 | 23 | 30 | 3 | GO:1990840 | |
| GeneOntologyBiologicalProcess | toll-like receptor 3 signaling pathway | 1.21e-05 | 31 | 30 | 3 | GO:0034138 | |
| GeneOntologyBiologicalProcess | protein ubiquitination | 1.50e-05 | 811 | 30 | 8 | GO:0016567 | |
| GeneOntologyBiologicalProcess | innate immune response activating cell surface receptor signaling pathway | 1.69e-05 | 107 | 30 | 4 | GO:0002220 | |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 1.80e-05 | 228 | 30 | 5 | GO:0046777 | |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation | 2.99e-05 | 893 | 30 | 8 | GO:0032446 | |
| GeneOntologyBiologicalProcess | ephrin receptor signaling pathway | 6.55e-05 | 54 | 30 | 3 | GO:0048013 | |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | 7.12e-05 | 1009 | 30 | 8 | GO:0070647 | |
| GeneOntologyBiologicalProcess | endolysosomal toll-like receptor signaling pathway | 7.31e-05 | 56 | 30 | 3 | GO:0140894 | |
| GeneOntologyBiologicalProcess | Fc receptor signaling pathway | 9.91e-05 | 62 | 30 | 3 | GO:0038093 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine phosphorylation | 9.99e-05 | 327 | 30 | 5 | GO:0018108 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine modification | 1.03e-04 | 329 | 30 | 5 | GO:0018212 | |
| GeneOntologyBiologicalProcess | post-translational protein modification | 1.10e-04 | 1074 | 30 | 8 | GO:0043687 | |
| GeneOntologyBiologicalProcess | immune response-activating cell surface receptor signaling pathway | 1.55e-04 | 359 | 30 | 5 | GO:0002429 | |
| GeneOntologyBiologicalProcess | protein K63-linked ubiquitination | 1.82e-04 | 76 | 30 | 3 | GO:0070534 | |
| GeneOntologyBiologicalProcess | regulation of toll-like receptor 3 signaling pathway | 1.84e-04 | 14 | 30 | 2 | GO:0034139 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte activation | 2.14e-04 | 385 | 30 | 5 | GO:0051251 | |
| GeneOntologyBiologicalProcess | immune response-regulating cell surface receptor signaling pathway | 2.36e-04 | 393 | 30 | 5 | GO:0002768 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte activation | 3.31e-04 | 423 | 30 | 5 | GO:0002696 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte cell-cell adhesion | 4.26e-04 | 447 | 30 | 5 | GO:1903037 | |
| GeneOntologyBiologicalProcess | regulation of TORC1 signaling | 4.33e-04 | 102 | 30 | 3 | GO:1903432 | |
| GeneOntologyBiologicalProcess | positive regulation of cell activation | 4.35e-04 | 449 | 30 | 5 | GO:0050867 | |
| GeneOntologyBiologicalProcess | osteoclast development | 4.64e-04 | 22 | 30 | 2 | GO:0036035 | |
| GeneOntologyBiologicalProcess | bone cell development | 4.64e-04 | 22 | 30 | 2 | GO:0098751 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine autophosphorylation | 4.64e-04 | 22 | 30 | 2 | GO:0038083 | |
| GeneOntologyBiologicalProcess | regulation of T cell activation | 4.76e-04 | 458 | 30 | 5 | GO:0050863 | |
| GeneOntologyBiologicalProcess | TORC1 signaling | 5.25e-04 | 109 | 30 | 3 | GO:0038202 | |
| GeneOntologyBiologicalProcess | negative regulation of necroptotic process | 5.53e-04 | 24 | 30 | 2 | GO:0060546 | |
| GeneOntologyBiologicalProcess | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis | 6.01e-04 | 25 | 30 | 2 | GO:0002433 | |
| GeneOntologyBiologicalProcess | Fc-gamma receptor signaling pathway involved in phagocytosis | 6.01e-04 | 25 | 30 | 2 | GO:0038096 | |
| GeneOntologyBiologicalProcess | positive regulation of Ras protein signal transduction | 6.01e-04 | 25 | 30 | 2 | GO:0046579 | |
| GeneOntologyBiologicalProcess | leukocyte cell-cell adhesion | 6.23e-04 | 486 | 30 | 5 | GO:0007159 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | 6.24e-04 | 747 | 30 | 6 | GO:0007169 | |
| GeneOntologyBiologicalProcess | negative regulation of programmed necrotic cell death | 6.50e-04 | 26 | 30 | 2 | GO:0062099 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception of pain | 6.50e-04 | 26 | 30 | 2 | GO:0050966 | |
| GeneOntologyBiologicalProcess | cellular response to platelet-derived growth factor stimulus | 7.55e-04 | 28 | 30 | 2 | GO:0036120 | |
| GeneOntologyBiologicalProcess | T cell proliferation | 7.66e-04 | 288 | 30 | 4 | GO:0042098 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell activation | 7.86e-04 | 290 | 30 | 4 | GO:0050870 | |
| GeneOntologyBiologicalProcess | skeletal muscle cell proliferation | 8.10e-04 | 29 | 30 | 2 | GO:0014856 | |
| GeneOntologyBiologicalProcess | response to platelet-derived growth factor | 9.26e-04 | 31 | 30 | 2 | GO:0036119 | |
| GeneOntologyBiologicalProcess | chemosensory behavior | 9.26e-04 | 31 | 30 | 2 | GO:0007635 | |
| GeneOntologyBiologicalProcess | innate immune response-activating signaling pathway | 1.03e-03 | 312 | 30 | 4 | GO:0002758 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte cell-cell adhesion | 1.09e-03 | 317 | 30 | 4 | GO:1903039 | |
| GeneOntologyBiologicalProcess | immune response-activating signaling pathway | 1.11e-03 | 553 | 30 | 5 | GO:0002757 | |
| GeneOntologyBiologicalProcess | neurotrophin TRK receptor signaling pathway | 1.11e-03 | 34 | 30 | 2 | GO:0048011 | |
| GeneOntologyBiologicalProcess | Fc receptor mediated stimulatory signaling pathway | 1.18e-03 | 35 | 30 | 2 | GO:0002431 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | 1.29e-03 | 1186 | 30 | 7 | GO:0007167 | |
| GeneOntologyBiologicalProcess | activation of innate immune response | 1.31e-03 | 333 | 30 | 4 | GO:0002218 | |
| GeneOntologyBiologicalProcess | negative regulation of inflammatory response to antigenic stimulus | 1.32e-03 | 37 | 30 | 2 | GO:0002862 | |
| GeneOntologyBiologicalProcess | regulation of necroptotic process | 1.32e-03 | 37 | 30 | 2 | GO:0060544 | |
| GeneOntologyBiologicalProcess | regulation of DNA recombination | 1.33e-03 | 150 | 30 | 3 | GO:0000018 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | 1.38e-03 | 580 | 30 | 5 | GO:0022407 | |
| GeneOntologyBiologicalProcess | Fc-gamma receptor signaling pathway | 1.47e-03 | 39 | 30 | 2 | GO:0038094 | |
| GeneOntologyBiologicalProcess | regulation of TOR signaling | 1.54e-03 | 158 | 30 | 3 | GO:0032006 | |
| GeneOntologyBiologicalProcess | T cell receptor signaling pathway | 1.59e-03 | 160 | 30 | 3 | GO:0050852 | |
| GeneOntologyBiologicalProcess | osteoclast differentiation | 1.65e-03 | 162 | 30 | 3 | GO:0030316 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte activation | 1.77e-03 | 614 | 30 | 5 | GO:0051249 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception of pain | 1.78e-03 | 43 | 30 | 2 | GO:0062149 | |
| GeneOntologyBiologicalProcess | regulation of programmed necrotic cell death | 1.78e-03 | 43 | 30 | 2 | GO:0062098 | |
| GeneOntologyBiologicalProcess | immune response-regulating signaling pathway | 1.78e-03 | 615 | 30 | 5 | GO:0002764 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair via homologous recombination | 1.86e-03 | 44 | 30 | 2 | GO:1905168 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide catabolic process | 1.86e-03 | 169 | 30 | 3 | GO:0009154 | |
| GeneOntologyBiologicalProcess | activation of immune response | 1.88e-03 | 623 | 30 | 5 | GO:0002253 | |
| GeneOntologyBiologicalProcess | DNA recombination | 1.89e-03 | 368 | 30 | 4 | GO:0006310 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte proliferation | 1.90e-03 | 170 | 30 | 3 | GO:0050671 | |
| GeneOntologyBiologicalProcess | learning or memory | 1.99e-03 | 373 | 30 | 4 | GO:0007611 | |
| GeneOntologyBiologicalProcess | positive regulation of mononuclear cell proliferation | 1.99e-03 | 173 | 30 | 3 | GO:0032946 | |
| GeneOntologyBiologicalProcess | positive regulation of protein modification process | 2.01e-03 | 937 | 30 | 6 | GO:0031401 | |
| GeneOntologyBiologicalProcess | neurotrophin signaling pathway | 2.12e-03 | 47 | 30 | 2 | GO:0038179 | |
| GeneOntologyBiologicalProcess | cellular response to reactive oxygen species | 2.16e-03 | 178 | 30 | 3 | GO:0034614 | |
| GeneOntologyBiologicalProcess | ribonucleotide catabolic process | 2.16e-03 | 178 | 30 | 3 | GO:0009261 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular signal transduction | 2.18e-03 | 1299 | 30 | 7 | GO:1902533 | |
| GeneOntologyBiologicalProcess | TOR signaling | 2.27e-03 | 181 | 30 | 3 | GO:0031929 | |
| GeneOntologyBiologicalProcess | purine nucleotide catabolic process | 2.30e-03 | 182 | 30 | 3 | GO:0006195 | |
| GeneOntologyBiologicalProcess | cellular response to amyloid-beta | 2.30e-03 | 49 | 30 | 2 | GO:1904646 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-cell adhesion | 2.32e-03 | 389 | 30 | 4 | GO:0022409 | |
| GeneOntologyBiologicalProcess | lymphocyte activation | 2.47e-03 | 976 | 30 | 6 | GO:0046649 | |
| GeneOntologyBiologicalProcess | response to pain | 2.49e-03 | 51 | 30 | 2 | GO:0048265 | |
| GeneOntologyBiologicalProcess | T cell costimulation | 2.49e-03 | 51 | 30 | 2 | GO:0031295 | |
| GeneOntologyBiologicalProcess | lymphocyte proliferation | 2.52e-03 | 398 | 30 | 4 | GO:0046651 | |
| GeneOntologyBiologicalProcess | purine-containing compound catabolic process | 2.52e-03 | 188 | 30 | 3 | GO:0072523 | |
| GeneOntologyBiologicalProcess | double-strand break repair via homologous recombination | 2.52e-03 | 188 | 30 | 3 | GO:0000724 | |
| GeneOntologyBiologicalProcess | cytoplasmic pattern recognition receptor signaling pathway | 2.52e-03 | 188 | 30 | 3 | GO:0002753 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte proliferation | 2.64e-03 | 191 | 30 | 3 | GO:0070665 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | 2.68e-03 | 405 | 30 | 4 | GO:0033674 | |
| GeneOntologyBiologicalProcess | necroptotic process | 2.69e-03 | 53 | 30 | 2 | GO:0070266 | |
| GeneOntologyBiologicalProcess | lymphocyte costimulation | 2.69e-03 | 53 | 30 | 2 | GO:0031294 | |
| GeneOntologyBiologicalProcess | mononuclear cell proliferation | 2.70e-03 | 406 | 30 | 4 | GO:0032943 | |
| GeneOntologyBiologicalProcess | recombinational repair | 2.76e-03 | 194 | 30 | 3 | GO:0000725 | |
| GeneOntologyBiologicalProcess | cell activation | 2.79e-03 | 1356 | 30 | 7 | GO:0001775 | |
| GeneOntologyCellularComponent | connexin complex | 4.83e-04 | 22 | 31 | 2 | GO:0005922 | |
| GeneOntologyCellularComponent | site of DNA damage | 1.08e-03 | 137 | 31 | 3 | GO:0090734 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 1.08e-03 | 137 | 31 | 3 | GO:0019897 | |
| GeneOntologyCellularComponent | actin filament | 1.30e-03 | 146 | 31 | 3 | GO:0005884 | |
| GeneOntologyCellularComponent | gap junction | 1.37e-03 | 37 | 31 | 2 | GO:0005921 | |
| MousePheno | abnormal T cell clonal deletion | 3.87e-05 | 6 | 23 | 2 | MP:0005002 | |
| MousePheno | abnormal clonal deletion | 3.87e-05 | 6 | 23 | 2 | MP:0005001 | |
| MousePheno | ectopic hippocampus pyramidal cells | 5.41e-05 | 7 | 23 | 2 | MP:0010011 | |
| MousePheno | abnormal olfaction | 7.25e-05 | 50 | 23 | 3 | MP:0001984 | |
| MousePheno | abnormal olfactory system physiology | 1.13e-04 | 58 | 23 | 3 | MP:0001983 | |
| MousePheno | decreased molar number | 2.33e-04 | 14 | 23 | 2 | MP:0006400 | |
| MousePheno | abnormal negative T cell selection | 2.33e-04 | 14 | 23 | 2 | MP:0004918 | |
| MousePheno | absent incisors | 2.68e-04 | 15 | 23 | 2 | MP:0000125 | |
| Domain | TyrKc | 2.69e-07 | 88 | 30 | 5 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 2.69e-07 | 88 | 30 | 5 | IPR020635 | |
| Domain | PROTEIN_KINASE_TYR | 4.38e-07 | 97 | 30 | 5 | PS00109 | |
| Domain | Tyr_kinase_AS | 4.38e-07 | 97 | 30 | 5 | IPR008266 | |
| Domain | Pkinase_Tyr | 1.80e-06 | 129 | 30 | 5 | PF07714 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 2.52e-06 | 138 | 30 | 5 | IPR001245 | |
| Domain | SH2 | 1.98e-05 | 101 | 30 | 4 | PF00017 | |
| Domain | SH2 | 2.77e-05 | 110 | 30 | 4 | SM00252 | |
| Domain | SH2 | 2.87e-05 | 111 | 30 | 4 | PS50001 | |
| Domain | SH2 | 2.98e-05 | 112 | 30 | 4 | IPR000980 | |
| Domain | - | 2.98e-05 | 112 | 30 | 4 | 3.30.505.10 | |
| Domain | - | 6.79e-05 | 449 | 30 | 6 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 7.67e-05 | 459 | 30 | 6 | IPR013083 | |
| Domain | ZF_RING_1 | 9.18e-05 | 291 | 30 | 5 | PS00518 | |
| Domain | ZF_RING_2 | 1.03e-04 | 298 | 30 | 5 | PS50089 | |
| Domain | RING | 1.15e-04 | 305 | 30 | 5 | SM00184 | |
| Domain | Znf_RING | 1.56e-04 | 326 | 30 | 5 | IPR001841 | |
| Domain | BBOX | 1.82e-04 | 69 | 30 | 3 | SM00336 | |
| Domain | Butyrophylin | 1.90e-04 | 70 | 30 | 3 | IPR003879 | |
| Domain | - | 1.99e-04 | 71 | 30 | 3 | 4.10.45.10 | |
| Domain | zf-B_box | 2.07e-04 | 72 | 30 | 3 | PF00643 | |
| Domain | ZF_BBOX | 2.83e-04 | 80 | 30 | 3 | PS50119 | |
| Domain | Znf_B-box | 2.93e-04 | 81 | 30 | 3 | IPR000315 | |
| Domain | Protein_kinase_ATP_BS | 3.14e-04 | 379 | 30 | 5 | IPR017441 | |
| Domain | SPRY | 3.62e-04 | 87 | 30 | 3 | SM00449 | |
| Domain | CONNEXINS_1 | 4.19e-04 | 19 | 30 | 2 | PS00407 | |
| Domain | SPRY | 4.54e-04 | 94 | 30 | 3 | PF00622 | |
| Domain | SPRY_dom | 4.54e-04 | 94 | 30 | 3 | IPR003877 | |
| Domain | Connexin_N | 4.65e-04 | 20 | 30 | 2 | IPR013092 | |
| Domain | CONNEXINS_2 | 4.65e-04 | 20 | 30 | 2 | PS00408 | |
| Domain | Connexin | 4.65e-04 | 20 | 30 | 2 | PF00029 | |
| Domain | Connexin_CCC | 4.65e-04 | 20 | 30 | 2 | SM01089 | |
| Domain | Connexin_CS | 4.65e-04 | 20 | 30 | 2 | IPR017990 | |
| Domain | Connexin | 4.65e-04 | 20 | 30 | 2 | IPR000500 | |
| Domain | Connexin_CCC | 4.65e-04 | 20 | 30 | 2 | IPR019570 | |
| Domain | CNX | 4.65e-04 | 20 | 30 | 2 | SM00037 | |
| Domain | B30.2/SPRY | 4.69e-04 | 95 | 30 | 3 | IPR001870 | |
| Domain | B302_SPRY | 4.69e-04 | 95 | 30 | 3 | PS50188 | |
| Domain | PROTEIN_KINASE_ATP | 7.52e-04 | 459 | 30 | 5 | PS00107 | |
| Domain | Prot_kinase_dom | 1.00e-03 | 489 | 30 | 5 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 1.04e-03 | 493 | 30 | 5 | PS50011 | |
| Domain | Arm | 1.13e-03 | 31 | 30 | 2 | PF00514 | |
| Domain | Kinase-like_dom | 1.58e-03 | 542 | 30 | 5 | IPR011009 | |
| Domain | ARM | 1.87e-03 | 40 | 30 | 2 | SM00185 | |
| Domain | ARM_REPEAT | 1.87e-03 | 40 | 30 | 2 | PS50176 | |
| Domain | Armadillo | 2.58e-03 | 47 | 30 | 2 | IPR000225 | |
| Domain | SH3 | 4.92e-03 | 216 | 30 | 3 | PS50002 | |
| Domain | SH3 | 4.92e-03 | 216 | 30 | 3 | SM00326 | |
| Domain | ConA-like_dom | 5.11e-03 | 219 | 30 | 3 | IPR013320 | |
| Domain | SH3_domain | 5.18e-03 | 220 | 30 | 3 | IPR001452 | |
| Domain | EGF_CA | 8.38e-03 | 86 | 30 | 2 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 1.06e-02 | 97 | 30 | 2 | IPR018097 | |
| Domain | EGF_CA | 1.10e-02 | 99 | 30 | 2 | PS01187 | |
| Pathway | PID_P38_ALPHA_BETA_PATHWAY | 1.30e-05 | 30 | 22 | 3 | M76 | |
| Pathway | WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING | 1.79e-05 | 218 | 22 | 5 | M42569 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 4.19e-05 | 44 | 22 | 3 | MM14606 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FYN | 4.86e-05 | 7 | 22 | 2 | M27912 | |
| Pathway | PID_PI3KCI_PATHWAY | 5.45e-05 | 48 | 22 | 3 | M141 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 6.54e-05 | 51 | 22 | 3 | M26972 | |
| Pathway | WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING | 6.62e-05 | 144 | 22 | 4 | M39691 | |
| Pathway | PID_CD8_TCR_PATHWAY | 7.35e-05 | 53 | 22 | 3 | M88 | |
| Pathway | REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING | 8.31e-05 | 9 | 22 | 2 | MM15059 | |
| Pathway | BIOCARTA_TCRA_PATHWAY | 8.31e-05 | 9 | 22 | 2 | MM1429 | |
| Pathway | PID_TCR_PATHWAY | 1.29e-04 | 64 | 22 | 3 | M34 | |
| Pathway | REACTOME_PECAM1_INTERACTIONS | 1.52e-04 | 12 | 22 | 2 | MM14835 | |
| Pathway | REACTOME_PECAM1_INTERACTIONS | 1.52e-04 | 12 | 22 | 2 | M11773 | |
| Pathway | REACTOME_REGULATION_OF_KIT_SIGNALING | 1.79e-04 | 13 | 22 | 2 | MM14565 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 2.07e-04 | 75 | 22 | 3 | MM14652 | |
| Pathway | BIOCARTA_TCRA_PATHWAY | 2.09e-04 | 14 | 22 | 2 | M10765 | |
| Pathway | REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING | 2.09e-04 | 14 | 22 | 2 | M889 | |
| Pathway | REACTOME_IRAK1_RECRUITS_IKK_COMPLEX | 2.09e-04 | 14 | 22 | 2 | M935 | |
| Pathway | WP_PROLACTIN_SIGNALING | 2.15e-04 | 76 | 22 | 3 | M39601 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 2.41e-04 | 15 | 22 | 2 | MM14965 | |
| Pathway | REACTOME_IRAK1_RECRUITS_IKK_COMPLEX | 2.41e-04 | 15 | 22 | 2 | MM15645 | |
| Pathway | REACTOME_REGULATION_OF_KIT_SIGNALING | 2.75e-04 | 16 | 22 | 2 | M537 | |
| Pathway | PID_SYNDECAN_3_PATHWAY | 3.12e-04 | 17 | 22 | 2 | M251 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 3.50e-04 | 18 | 22 | 2 | MM15023 | |
| Pathway | REACTOME_EPHRIN_SIGNALING | 3.50e-04 | 18 | 22 | 2 | MM15024 | |
| Pathway | WP_TCELL_RECEPTOR_SIGNALING | 3.55e-04 | 90 | 22 | 3 | M39725 | |
| Pathway | REACTOME_EPHRIN_SIGNALING | 3.91e-04 | 19 | 22 | 2 | M27310 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY | 3.91e-04 | 19 | 22 | 2 | M47733 | |
| Pathway | REACTOME_SIGNALLING_TO_RAS | 4.34e-04 | 20 | 22 | 2 | M12256 | |
| Pathway | REACTOME_SIGNALING_BY_KIT_IN_DISEASE | 4.34e-04 | 20 | 22 | 2 | M39002 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 4.80e-04 | 21 | 22 | 2 | M5876 | |
| Pathway | WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX | 4.80e-04 | 21 | 22 | 2 | M39876 | |
| Pathway | PID_ECADHERIN_KERATINOCYTE_PATHWAY | 4.80e-04 | 21 | 22 | 2 | M184 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 4.80e-04 | 21 | 22 | 2 | MM14996 | |
| Pathway | WP_NRF2ARE_REGULATION | 5.77e-04 | 23 | 22 | 2 | M39761 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 6.73e-04 | 112 | 22 | 3 | MM15214 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK2_TRKB | 6.82e-04 | 25 | 22 | 2 | M27864 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 6.91e-04 | 113 | 22 | 3 | MM14783 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 7.84e-04 | 118 | 22 | 3 | M713 | |
| Pathway | PID_GLYPICAN_1PATHWAY | 7.97e-04 | 27 | 22 | 2 | M33 | |
| Pathway | WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING | 8.57e-04 | 28 | 22 | 2 | M39632 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 9.20e-04 | 29 | 22 | 2 | M27309 | |
| Pathway | PID_EPHRINB_REV_PATHWAY | 9.85e-04 | 30 | 22 | 2 | M257 | |
| Pathway | REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM | 1.04e-03 | 789 | 22 | 6 | M1060 | |
| Pathway | REACTOME_SIGNALING_BY_CSF1_M_CSF_IN_MYELOID_CELLS | 1.05e-03 | 31 | 22 | 2 | M46423 | |
| Pathway | PID_ALPHA_SYNUCLEIN_PATHWAY | 1.12e-03 | 32 | 22 | 2 | M275 | |
| Pathway | PID_NETRIN_PATHWAY | 1.12e-03 | 32 | 22 | 2 | M108 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 1.12e-03 | 32 | 22 | 2 | MM14730 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 1.13e-03 | 134 | 22 | 3 | M3574 | |
| Pathway | REACTOME_CD28_CO_STIMULATION | 1.19e-03 | 33 | 22 | 2 | M11725 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 1.27e-03 | 34 | 22 | 2 | MM15025 | |
| Pathway | REACTOME_SIGNALLING_TO_ERKS | 1.27e-03 | 34 | 22 | 2 | M13881 | |
| Pathway | PID_EPHA_FWDPATHWAY | 1.27e-03 | 34 | 22 | 2 | M177 | |
| Pathway | REACTOME_CD28_CO_STIMULATION | 1.27e-03 | 34 | 22 | 2 | MM14992 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 1.29e-03 | 140 | 22 | 3 | M27484 | |
| Pathway | PID_PI3KCI_AKT_PATHWAY | 1.34e-03 | 35 | 22 | 2 | M249 | |
| Pathway | PID_PI3K_PLC_TRK_PATHWAY | 1.42e-03 | 36 | 22 | 2 | M271 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 1.50e-03 | 37 | 22 | 2 | MM15022 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 1.50e-03 | 37 | 22 | 2 | MM14564 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 1.58e-03 | 38 | 22 | 2 | M14981 | |
| Pathway | WP_IL1_SIGNALING_PATHWAY | 1.66e-03 | 39 | 22 | 2 | MM15996 | |
| Pathway | PID_AMB2_NEUTROPHILS_PATHWAY | 1.84e-03 | 41 | 22 | 2 | M159 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 1.93e-03 | 42 | 22 | 2 | M27308 | |
| Pathway | BIOCARTA_TCR_PATHWAY | 1.93e-03 | 42 | 22 | 2 | MM1504 | |
| Pathway | WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING | 2.02e-03 | 43 | 22 | 2 | M39744 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 2.02e-03 | 43 | 22 | 2 | M508 | |
| Pathway | WP_IL11_SIGNALING | 2.11e-03 | 44 | 22 | 2 | M39716 | |
| Pathway | BIOCARTA_TCR_PATHWAY | 2.11e-03 | 44 | 22 | 2 | M19784 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 2.11e-03 | 44 | 22 | 2 | M875 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 2.11e-03 | 44 | 22 | 2 | MM14520 | |
| Pathway | WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING | 2.41e-03 | 47 | 22 | 2 | M39380 | |
| Pathway | WP_MICROTUBULE_CYTOSKELETON_REGULATION | 2.51e-03 | 48 | 22 | 2 | M39566 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 2.51e-03 | 48 | 22 | 2 | MM17214 | |
| Pathway | PID_AJDISS_2PATHWAY | 2.51e-03 | 48 | 22 | 2 | M142 | |
| Pathway | WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING_PATHWAY | 2.51e-03 | 48 | 22 | 2 | MM15897 | |
| Pathway | WP_IL3_SIGNALING | 2.62e-03 | 49 | 22 | 2 | M39722 | |
| Pathway | KEGG_ENDOCYTOSIS | 2.68e-03 | 181 | 22 | 3 | M1519 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 2.72e-03 | 50 | 22 | 2 | M553 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 2.83e-03 | 51 | 22 | 2 | M27311 | |
| Pathway | WP_FOCAL_ADHESION | 2.94e-03 | 187 | 22 | 3 | MM15913 | |
| Pathway | WP_NETRINUNC5B_SIGNALING | 2.94e-03 | 52 | 22 | 2 | M39782 | |
| Pathway | PID_PTP1B_PATHWAY | 2.94e-03 | 52 | 22 | 2 | M50 | |
| Pathway | WP_INTERFERON_TYPE_I_SIGNALING | 3.17e-03 | 54 | 22 | 2 | M39435 | |
| Pathway | WP_IL1_SIGNALING | 3.28e-03 | 55 | 22 | 2 | M39346 | |
| Pathway | WP_RANKLRANK_SIGNALING | 3.28e-03 | 55 | 22 | 2 | M39667 | |
| Pathway | PID_TXA2PATHWAY | 3.40e-03 | 56 | 22 | 2 | M99 | |
| Pathway | WP_FOCAL_ADHESION | 3.50e-03 | 199 | 22 | 3 | M39402 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 3.65e-03 | 418 | 22 | 4 | MM15587 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING | 3.77e-03 | 59 | 22 | 2 | M39350 | |
| Pathway | PID_FAK_PATHWAY | 3.77e-03 | 59 | 22 | 2 | M281 | |
| Pathway | WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION | 4.02e-03 | 61 | 22 | 2 | M42548 | |
| Pathway | WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION | 4.15e-03 | 62 | 22 | 2 | M39429 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 4.29e-03 | 63 | 22 | 2 | M11187 | |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | 4.34e-03 | 719 | 22 | 5 | MM14540 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 4.56e-03 | 65 | 22 | 2 | MM14911 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 4.69e-03 | 66 | 22 | 2 | MM15925 | |
| Pathway | REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY | 4.69e-03 | 66 | 22 | 2 | MM14990 | |
| Pathway | KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION | 4.98e-03 | 68 | 22 | 2 | M16848 | |
| Pathway | PID_P75_NTR_PATHWAY | 4.98e-03 | 68 | 22 | 2 | M153 | |
| Pathway | PID_VEGFR1_2_PATHWAY | 5.12e-03 | 69 | 22 | 2 | M237 | |
| Pubmed | Identification of a genomic reservoir for new TRIM genes in primate genomes. | 1.98e-09 | 19 | 31 | 4 | 22144910 | |
| Pubmed | 6.40e-09 | 5 | 31 | 3 | 22447928 | ||
| Pubmed | 1.11e-08 | 83 | 31 | 5 | 11114734 | ||
| Pubmed | 7.66e-08 | 10 | 31 | 3 | 9062339 | ||
| Pubmed | The SRC-family tyrosine kinase HCK shapes the landscape of SKAP2 interactome. | 2.32e-07 | 14 | 31 | 3 | 29568343 | |
| Pubmed | 2.90e-07 | 15 | 31 | 3 | 19703589 | ||
| Pubmed | Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain. | 7.69e-07 | 2 | 31 | 2 | 8681387 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 22354875 | ||
| Pubmed | A role for Fyn in Trk receptor transactivation by G-protein-coupled receptor signaling. | 7.69e-07 | 2 | 31 | 2 | 16860569 | |
| Pubmed | Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke. | 7.69e-07 | 2 | 31 | 2 | 11175854 | |
| Pubmed | Tumor metastasis but not tumor growth is dependent on Src-mediated vascular permeability. | 7.69e-07 | 2 | 31 | 2 | 15486073 | |
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 11994463 | ||
| Pubmed | 7.69e-07 | 2 | 31 | 2 | 24369899 | ||
| Pubmed | c-Src but not Fyn promotes proper spindle orientation in early prometaphase. | 7.69e-07 | 2 | 31 | 2 | 22689581 | |
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 16246731 | ||
| Pubmed | Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. | 2.31e-06 | 3 | 31 | 2 | 12089510 | |
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 12695509 | ||
| Pubmed | Src family kinases are required for integrin but not PDGFR signal transduction. | 2.31e-06 | 3 | 31 | 2 | 10228160 | |
| Pubmed | Raf-1 interacts with Fyn and Src in a non-phosphotyrosine-dependent manner. | 2.31e-06 | 3 | 31 | 2 | 7517401 | |
| Pubmed | Localized activation of Src-family protein kinases in the mouse egg. | 2.31e-06 | 3 | 31 | 2 | 17449027 | |
| Pubmed | Combined deficiencies of Src, Fyn, and Yes tyrosine kinases in mutant mice. | 2.31e-06 | 3 | 31 | 2 | 7958873 | |
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 22011838 | ||
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 23497302 | ||
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 16859680 | ||
| Pubmed | Differential transformation capacity of Src family kinases during the initiation of prostate cancer. | 2.31e-06 | 3 | 31 | 2 | 21464326 | |
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 12932824 | ||
| Pubmed | Src, Fyn and Yes play differential roles in VEGF-mediated endothelial cell events. | 2.31e-06 | 3 | 31 | 2 | 16400523 | |
| Pubmed | Requirement of SRC-family tyrosine kinases in fat accumulation. | 2.31e-06 | 3 | 31 | 2 | 16262245 | |
| Pubmed | Requirements for activation and RAFT localization of the T-lymphocyte kinase Rlk/Txk. | 2.31e-06 | 3 | 31 | 2 | 11353545 | |
| Pubmed | Anthrax toxin triggers the activation of src-like kinases to mediate its own uptake. | 2.31e-06 | 3 | 31 | 2 | 20080640 | |
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 20176789 | ||
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 11483655 | ||
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 19690143 | ||
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 8983085 | ||
| Pubmed | TRAF6 and C-SRC induce synergistic AP-1 activation via PI3-kinase-AKT-JNK pathway. | 2.31e-06 | 3 | 31 | 2 | 12631284 | |
| Pubmed | Regulation of TRPC6 channel activity by tyrosine phosphorylation. | 2.31e-06 | 3 | 31 | 2 | 14761972 | |
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 15297464 | ||
| Pubmed | Disease-related modifications in tau affect the interaction between Fyn and Tau. | 2.31e-06 | 3 | 31 | 2 | 16115884 | |
| Pubmed | Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. | 2.31e-06 | 3 | 31 | 2 | 10635317 | |
| Pubmed | Specific and redundant roles of Src and Fyn in organizing the cytoskeleton. | 2.31e-06 | 3 | 31 | 2 | 7617039 | |
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 25053806 | ||
| Pubmed | 2.31e-06 | 3 | 31 | 2 | 11024032 | ||
| Pubmed | 4.49e-06 | 36 | 31 | 3 | 22422068 | ||
| Pubmed | Amyloid β-abrogated TrkA ubiquitination in PC12 cells analogous to Alzheimer's disease. | 4.61e-06 | 4 | 31 | 2 | 25708205 | |
| Pubmed | Identification of Grb10 as a direct substrate for members of the Src tyrosine kinase family. | 4.61e-06 | 4 | 31 | 2 | 10871840 | |
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 29545793 | ||
| Pubmed | Identification of a consensus site for TRAF6/p62 polyubiquitination. | 4.61e-06 | 4 | 31 | 2 | 18457658 | |
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 10867021 | ||
| Pubmed | RT loop flexibility enhances the specificity of Src family SH3 domains for HIV-1 Nef. | 4.61e-06 | 4 | 31 | 2 | 9778343 | |
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 9118959 | ||
| Pubmed | Src kinase phosphorylates RUNX3 at tyrosine residues and localizes the protein in the cytoplasm. | 4.61e-06 | 4 | 31 | 2 | 20100835 | |
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 7681396 | ||
| Pubmed | Activation of FAK and Src are receptor-proximal events required for netrin signaling. | 4.61e-06 | 4 | 31 | 2 | 15494734 | |
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 10458595 | ||
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 15872086 | ||
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 11245687 | ||
| Pubmed | Autophosphorylation activity and association with Src family kinase of Sky receptor tyrosine kinase. | 4.61e-06 | 4 | 31 | 2 | 7537495 | |
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 17094785 | ||
| Pubmed | Endocytosis of collagen by hepatic stellate cells regulates extracellular matrix dynamics. | 4.61e-06 | 4 | 31 | 2 | 25080486 | |
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 16014719 | ||
| Pubmed | alpha-synuclein is phosphorylated by members of the Src family of protein-tyrosine kinases. | 4.61e-06 | 4 | 31 | 2 | 11078745 | |
| Pubmed | T-cell receptor antagonists induce Vav phosphorylation by selective activation of Fyn kinase. | 4.61e-06 | 4 | 31 | 2 | 11005864 | |
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 19258394 | ||
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 16585062 | ||
| Pubmed | Src promotes GTPase activity of Ras via tyrosine 32 phosphorylation. | 4.61e-06 | 4 | 31 | 2 | 25157176 | |
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 7521304 | ||
| Pubmed | Force sensing by mechanical extension of the Src family kinase substrate p130Cas. | 4.61e-06 | 4 | 31 | 2 | 17129785 | |
| Pubmed | State and role of SRC family kinases in replication of herpes simplex virus 1. | 4.61e-06 | 4 | 31 | 2 | 16537602 | |
| Pubmed | Tau interacts with src-family non-receptor tyrosine kinases. | 4.61e-06 | 4 | 31 | 2 | 9763511 | |
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 16882656 | ||
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 14559149 | ||
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 21541365 | ||
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 15491611 | ||
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 35058288 | ||
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 7760813 | ||
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 8551236 | ||
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 19304944 | ||
| Pubmed | 7.48e-06 | 141 | 31 | 4 | 20056178 | ||
| Pubmed | Palatal adhesion is dependent on Src family kinases and p38MAPK. | 7.68e-06 | 5 | 31 | 2 | 25354453 | |
| Pubmed | Clustering-induced tyrosine phosphorylation of nephrin by Src family kinases. | 7.68e-06 | 5 | 31 | 2 | 12846735 | |
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 11149959 | ||
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 16479011 | ||
| Pubmed | Calpain II colocalizes with detergent-insoluble rafts on human and Jurkat T-cells. | 7.68e-06 | 5 | 31 | 2 | 12150984 | |
| Pubmed | A ligand-independent VEGFR2 signaling pathway limits angiogenic responses in diabetes. | 7.68e-06 | 5 | 31 | 2 | 24399295 | |
| Pubmed | Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. | 7.68e-06 | 5 | 31 | 2 | 18194650 | |
| Pubmed | Essential role of sequestosome 1/p62 in regulating accumulation of Lys63-ubiquitinated proteins. | 7.68e-06 | 5 | 31 | 2 | 18174161 | |
| Pubmed | Magicin associates with the Src-family kinases and is phosphorylated upon CD3 stimulation. | 7.68e-06 | 5 | 31 | 2 | 16899217 | |
| Pubmed | Focal adhesion kinase is required for β-catenin-induced mobilization of epidermal stem cells. | 7.68e-06 | 5 | 31 | 2 | 22971575 | |
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 17394141 | ||
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 9195899 | ||
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 10739664 | ||
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 37977223 | ||
| Pubmed | Protein-tyrosine Phosphatase and Kinase Specificity in Regulation of SRC and Breast Tumor Kinase. | 7.68e-06 | 5 | 31 | 2 | 25897081 | |
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 18255094 | ||
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 17623777 | ||
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 17785434 | ||
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 12509223 | ||
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 29720226 | ||
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 11448999 | ||
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 12941616 | ||
| Interaction | IL1R1 interactions | 1.56e-05 | 34 | 29 | 3 | int:IL1R1 | |
| Interaction | CBLB interactions | 2.14e-05 | 115 | 29 | 4 | int:CBLB | |
| Interaction | SOS1 interactions | 2.29e-05 | 117 | 29 | 4 | int:SOS1 | |
| Interaction | WASL interactions | 2.29e-05 | 117 | 29 | 4 | int:WASL | |
| Interaction | SH3BP2 interactions | 4.44e-05 | 48 | 29 | 3 | int:SH3BP2 | |
| Interaction | SPHK1 interactions | 4.72e-05 | 49 | 29 | 3 | int:SPHK1 | |
| Interaction | SKAP2 interactions | 5.33e-05 | 51 | 29 | 3 | int:SKAP2 | |
| Interaction | PCDHGC3 interactions | 6.32e-05 | 54 | 29 | 3 | int:PCDHGC3 | |
| Interaction | TXK interactions | 7.44e-05 | 57 | 29 | 3 | int:TXK | |
| Interaction | GAB3 interactions | 1.09e-04 | 11 | 29 | 2 | int:GAB3 | |
| Interaction | PELI1 interactions | 1.10e-04 | 65 | 29 | 3 | int:PELI1 | |
| Interaction | PAG1 interactions | 1.21e-04 | 67 | 29 | 3 | int:PAG1 | |
| Interaction | AIP interactions | 1.28e-04 | 182 | 29 | 4 | int:AIP | |
| Interaction | PTPRC interactions | 1.32e-04 | 69 | 29 | 3 | int:PTPRC | |
| Interaction | SHC3 interactions | 1.49e-04 | 72 | 29 | 3 | int:SHC3 | |
| Interaction | AICDA interactions | 1.56e-04 | 73 | 29 | 3 | int:AICDA | |
| Interaction | DIS3 interactions | 1.64e-04 | 194 | 29 | 4 | int:DIS3 | |
| Interaction | CBLC interactions | 1.69e-04 | 75 | 29 | 3 | int:CBLC | |
| Interaction | ACBD7 interactions | 1.80e-04 | 14 | 29 | 2 | int:ACBD7 | |
| Interaction | WAS interactions | 2.80e-04 | 89 | 29 | 3 | int:WAS | |
| Interaction | SLC25A41 interactions | 2.89e-04 | 90 | 29 | 3 | int:SLC25A41 | |
| Interaction | RPS6KA3 interactions | 2.93e-04 | 226 | 29 | 4 | int:RPS6KA3 | |
| Interaction | COPG1 interactions | 3.09e-04 | 229 | 29 | 4 | int:COPG1 | |
| Interaction | ZAP70 interactions | 3.09e-04 | 92 | 29 | 3 | int:ZAP70 | |
| Interaction | HSPA4 interactions | 3.18e-04 | 667 | 29 | 6 | int:HSPA4 | |
| Interaction | TAMALIN interactions | 3.37e-04 | 19 | 29 | 2 | int:TAMALIN | |
| Interaction | SIT1 interactions | 3.37e-04 | 19 | 29 | 2 | int:SIT1 | |
| Interaction | HSP90AB1 interactions | 3.38e-04 | 960 | 29 | 7 | int:HSP90AB1 | |
| Interaction | NR3C1 interactions | 3.69e-04 | 974 | 29 | 7 | int:NR3C1 | |
| Interaction | USP7 interactions | 3.97e-04 | 1313 | 29 | 8 | int:USP7 | |
| Interaction | STAT3 interactions | 3.97e-04 | 446 | 29 | 5 | int:STAT3 | |
| Interaction | CD3G interactions | 4.13e-04 | 21 | 29 | 2 | int:CD3G | |
| Interaction | SYK interactions | 4.37e-04 | 251 | 29 | 4 | int:SYK | |
| Interaction | MAP2 interactions | 4.42e-04 | 104 | 29 | 3 | int:MAP2 | |
| Interaction | TRPV4 interactions | 4.54e-04 | 22 | 29 | 2 | int:TRPV4 | |
| Interaction | TRAF6 interactions | 4.81e-04 | 465 | 29 | 5 | int:TRAF6 | |
| Interaction | ABL1 interactions | 4.92e-04 | 259 | 29 | 4 | int:ABL1 | |
| Interaction | ZDHHC11 interactions | 4.96e-04 | 23 | 29 | 2 | int:ZDHHC11 | |
| Cytoband | 11p11.12 | 3.74e-04 | 42 | 31 | 2 | 11p11.12 | |
| Cytoband | 1p34.3 | 8.14e-04 | 62 | 31 | 2 | 1p34.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p34 | 1.02e-03 | 294 | 31 | 3 | chr1p34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p11 | 4.82e-03 | 153 | 31 | 2 | chr11p11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q14 | 5.00e-03 | 156 | 31 | 2 | chr11q14 | |
| Cytoband | 19p13.3 | 1.12e-02 | 237 | 31 | 2 | 19p13.3 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 1.14e-05 | 95 | 27 | 4 | 59 | |
| GeneFamily | SH2 domain containing | 1.46e-05 | 101 | 27 | 4 | 741 | |
| GeneFamily | Ring finger proteins | 4.82e-05 | 275 | 27 | 5 | 58 | |
| GeneFamily | Gap junction proteins | 4.87e-04 | 22 | 27 | 2 | 314 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.87e-03 | 43 | 27 | 2 | 409 | |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.LN, CD8 TCRb CD44high CD122high, Lymph Node, avg-3 | 4.36e-05 | 329 | 26 | 5 | GSM538395_500 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-06 | 169 | 31 | 4 | 2de213b083f57f47be58427c0ce127fee9f85caa | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 5.58e-06 | 169 | 31 | 4 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 7.01e-06 | 179 | 31 | 4 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-06 | 186 | 31 | 4 | 4dce1484653bb266e2305cbb306fb11eaf7892e2 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-06 | 186 | 31 | 4 | e23e1246914e230369a716d0d666b98383bf8512 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr-Polydendrocye.Tnr.Pdgfa_(Pdgfa)|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.31e-05 | 98 | 31 | 3 | 26250ea4171a0557a67505839cf79d3fe4d9d41a | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.31e-05 | 98 | 31 | 3 | 42875d16ae9fcbaf988cd71be82568f2f862f2dd | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1-P1_2|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.31e-05 | 98 | 31 | 3 | 7a62a77ca83153dacff4d02d6e32104227d0980d | |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Non-Seminoma-_Embryonal_Carcinoma,_Yolk_Sac_Tumor-1|TCGA-Testes / Sample_Type by Project: Shred V9 | 5.60e-05 | 107 | 31 | 3 | 80afce55e410aed65b565d2f432cefa39dae313d | |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Non-Seminoma-_Embryonal_Carcinoma-1|TCGA-Testes / Sample_Type by Project: Shred V9 | 1.09e-04 | 134 | 31 | 3 | d80c9168acbd316761330d29e994e7f9a30ad945 | |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Non-Seminoma-_Embryonal_Carcinoma|TCGA-Testes / Sample_Type by Project: Shred V9 | 1.22e-04 | 139 | 31 | 3 | 6b58d01ce9d9ac23434333f9faf1bb0eef14ba90 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.52e-04 | 150 | 31 | 3 | 70ac8ae4b1683fb17278a8e4606f2fa0b94988c0 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-04 | 155 | 31 | 3 | c58a5fb8d853f12204e961d633e83452eb12a659 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-04 | 155 | 31 | 3 | 9cb8c42c2e451b2d4dcd7154a4b1bfd21bbb7ea8 | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.78e-04 | 158 | 31 | 3 | 0d4fe87fc7901dd5f9c004e91708a03cafdb4ad9 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.4|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.02e-04 | 165 | 31 | 3 | 4d364e1aae41aea483d1311e5e8ef4fc33e30d5e | |
| ToppCell | Basal_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.05e-04 | 166 | 31 | 3 | 23c04d1fba0c1733ccd0e4378fae2edde4fd0a7b | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN4|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-04 | 167 | 31 | 3 | 10c9fab3573c2948081aac2cec1798e46e59e38a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.09e-04 | 167 | 31 | 3 | ded4d6cccd3660662f12cf5a512de31d26325f1b | |
| ToppCell | severe-HSPC|World / disease stage, cell group and cell class | 2.17e-04 | 169 | 31 | 3 | b0421b73bfdc92f7a2762b4b670b9eae124aa702 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-04 | 169 | 31 | 3 | 031465190cd3623a25ef2b868daab8d932c8ff08 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.24e-04 | 171 | 31 | 3 | 187b396059f8802265f54bad2b4882cebb809419 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.24e-04 | 171 | 31 | 3 | 2b7c5a557c4bc5c573211c4d618bdd6766a24916 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.24e-04 | 171 | 31 | 3 | 15cb4670ff4234ac46aea8a5911138d6913c4482 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.24e-04 | 171 | 31 | 3 | dcb15bc54aeea06ef8f07f1134f3ff1e21ac0e4f | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 172 | 31 | 3 | 4790323a072cfe76127d704665a42c09601d84be | |
| ToppCell | facs-Lung-Endomucin-24m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 173 | 31 | 3 | a37f38478473290fe35aea8684befc3bf95b161f | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 174 | 31 | 3 | 3340b44c77f55244e3c2e2ea479d42563f937040 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-04 | 174 | 31 | 3 | 47e308a777c927ae69ed344cb3dd8561bf2c48a5 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 174 | 31 | 3 | 5b00a795a9dd1a77305fcac5017cb276afdc1a27 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-04 | 174 | 31 | 3 | a92c745d20633909db0f08effa13fc738fda79a6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-04 | 175 | 31 | 3 | da92eb8af0c7c65fed4a1d960708240f35dd997d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-04 | 175 | 31 | 3 | 2f43883d7c89f09b0579a390a7431f1f9b832582 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 177 | 31 | 3 | d8b1bbc224d062a57a6ad40b4b2af5d6e0fe63b3 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 177 | 31 | 3 | 6d86b2f97426b552dff5ce6ddf0ead1285ed618e | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 177 | 31 | 3 | 36da06ca9577cdb7c7b5114e604f6546b9765c08 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 177 | 31 | 3 | ac0cf03e2a1baf84db3ae245d59bbc6ae52c13be | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 177 | 31 | 3 | 26bad614560609d318bfc9c235a698bca4e1c22c | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-NK-Activated_NK|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.52e-04 | 178 | 31 | 3 | 5b19dbf9dc8e41e6a16a2abbb798d49ee8d8653f | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-mature_NK_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.52e-04 | 178 | 31 | 3 | 28bb1e3e447261d0cb47e2b6343b17b2d74db525 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.56e-04 | 179 | 31 | 3 | ac0c257e63a5994282d8b350c1b517cc3fbee52a | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-TRDV2/TRGV9_gdT|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.56e-04 | 179 | 31 | 3 | f7d3d37505893ae55065c89d957084602729decc | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 180 | 31 | 3 | 978728c89497d26287f73974fb738ad9fde61415 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.61e-04 | 180 | 31 | 3 | f3d35b2ea78afef37a84232adf5e6e26712b618d | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.65e-04 | 181 | 31 | 3 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-Cd3e_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 181 | 31 | 3 | be7c7db6b99603759593e6f79cdcaa4bbf234cb7 | |
| ToppCell | IPF-Lymphoid-ILC_A|World / Disease state, Lineage and Cell class | 2.69e-04 | 182 | 31 | 3 | f91bb45baaec76cb3bb26eedbcf0709b2492e93f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-04 | 183 | 31 | 3 | dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-04 | 183 | 31 | 3 | 4759560e5b4f4e5a00e5f933e3451a27c7c4aefe | |
| ToppCell | IPF-Lymphoid-ILC_A|IPF / Disease state, Lineage and Cell class | 2.74e-04 | 183 | 31 | 3 | 49bfeaae13eb236f61a5486ee75c39789936bb8a | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 184 | 31 | 3 | c37c623c4a5ff1628486d8a6461fa355ad5c264c | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 184 | 31 | 3 | 8c23945bafe8926f25836bc208115edd5214a2b0 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-04 | 185 | 31 | 3 | 39f2b7a35253968f6d744c10ece1478a05cf24da | |
| ToppCell | facs-Marrow-T-cells-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-04 | 185 | 31 | 3 | e1fd0a807def8c2127194108b1a30c6de7024292 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-NK_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.87e-04 | 186 | 31 | 3 | 885aed2472cead81d60c9f3a28c0ff10eb449592 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-04 | 186 | 31 | 3 | 9d576dce2c5deefef1adda16c6da7055c8d57f8f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-04 | 186 | 31 | 3 | bd3bd022b575d9b0ef90d50a5cb874085a827b77 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-04 | 186 | 31 | 3 | 924cc357b4c4ce8e9b05773bdab544f0b65474cc | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.92e-04 | 187 | 31 | 3 | 6820bfbe552ea5e62cfe699687b051a17d9fda61 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.92e-04 | 187 | 31 | 3 | 442b7bf6bc17fc2d38bccd678be8994b0ead374f | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 2.92e-04 | 187 | 31 | 3 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.92e-04 | 187 | 31 | 3 | c0a18ab7d88420e20e478ccdce6a2cb0a60a7824 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.92e-04 | 187 | 31 | 3 | fda45c15806f34e45d44bb2e1d144591bc6eaa02 | |
| ToppCell | Fetal_29-31_weeks-Immune-natural_killer_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.96e-04 | 188 | 31 | 3 | 6686dbba990066568aa7573e70a7db8b4758f457 | |
| ToppCell | COVID-19-T_cells-CD8+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 3.01e-04 | 189 | 31 | 3 | 2c018d6120f65f0b2704b483bc9da1c0984872e3 | |
| ToppCell | Fetal_29-31_weeks-Immune-natural_killer_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.01e-04 | 189 | 31 | 3 | c604da558c9f4055fb36218452463539f2a73223 | |
| ToppCell | Control-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations) | 3.05e-04 | 190 | 31 | 3 | 0733be5e54fe15d6d6ea51c154a95258e83f1b92 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-04 | 190 | 31 | 3 | 07ea0578ca0561077557203ae660530f53fc4067 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.05e-04 | 190 | 31 | 3 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-04 | 190 | 31 | 3 | 5a37568000dfc33fcbb59b578c1963fb7cf872ec | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-04 | 190 | 31 | 3 | 5b4b3eed7aa798bb7e3c5e968c8dc4144e377a5f | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.05e-04 | 190 | 31 | 3 | 2a8de1cf27a9ebc3825cf9e7a489ecd064dfc7f9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-04 | 190 | 31 | 3 | ba61f04fd38efae01f721ba616252d1372ff1002 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Macrophage|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.05e-04 | 190 | 31 | 3 | e1c02fe6fa43a36381cb9f02569fa9b1c5f5efdc | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.05e-04 | 190 | 31 | 3 | 6de15ec88426fbf52acb0a8371f82cf03b6a6237 | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.10e-04 | 191 | 31 | 3 | 133864ec1e89f97a82c3bb01d2a3c658397fefaf | |
| ToppCell | COVID-19-lung-CD8+_T_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.10e-04 | 191 | 31 | 3 | 543f8ae07cc2e6950c888115a5ca9445e3c0f618 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-04 | 191 | 31 | 3 | d9506b88d806aadd4c2b9bf86fe994c47799e7f6 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.10e-04 | 191 | 31 | 3 | c7be771543089fc94e5c62fd22f745189642aec3 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.10e-04 | 191 | 31 | 3 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | Adult-Immune-T_lymphocyte-D175|Adult / Lineage, Cell type, age group and donor | 3.10e-04 | 191 | 31 | 3 | 0b84fd1dc68146d9f72422b102744d2847f5ecb2 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-04 | 191 | 31 | 3 | b42c54308abe1241cc38ddce96b9d38d07983891 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-04 | 191 | 31 | 3 | 96a7179a845d3daa046ed71fa45c51255f130a7f | |
| ToppCell | COVID-19-lung-CD4+_Treg|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.10e-04 | 191 | 31 | 3 | 5a4ad5ae5c2dbfb225158cb598ef649c26a48350 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.10e-04 | 191 | 31 | 3 | 81f77bf497b8e0ae0affe7d5f4f00446547229f6 | |
| ToppCell | COVID-19-T_cells-CD4+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 3.10e-04 | 191 | 31 | 3 | 0646cca78e24aeb6baa9934d3c439b797c567997 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-04 | 191 | 31 | 3 | 9aabbc65430e2233b8f2d3fff9face7807b88b48 | |
| ToppCell | COVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations) | 3.10e-04 | 191 | 31 | 3 | 7f64add931b64b8d35836fa6bee9ebab593844d3 | |
| ToppCell | COVID-19-lung-CD4+_Treg|lung / Disease (COVID-19 only), tissue and cell type | 3.10e-04 | 191 | 31 | 3 | 73ea3078c1f55cd47e4d99e77b3ce4ff17549d49 | |
| ToppCell | COPD-Lymphoid|COPD / Disease state, Lineage and Cell class | 3.15e-04 | 192 | 31 | 3 | 064fefb8212fadab0ff441f4bf643559b7fdb25d | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.15e-04 | 192 | 31 | 3 | dceb8b38c2ddb1a848132bd52edc8e883e7d2aa9 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-Tregs|lymph-node_spleen / Manually curated celltypes from each tissue | 3.15e-04 | 192 | 31 | 3 | 04bd6e135733570e877af9460f87379ed0a5c5f8 | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.15e-04 | 192 | 31 | 3 | 69a2b04f03a1b82d067018379f7b8a116e954040 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 3.15e-04 | 192 | 31 | 3 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-04 | 192 | 31 | 3 | b498618505bb1b7ff9574d06875dd272c11bac39 | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|COPD / Disease state, Lineage and Cell class | 3.20e-04 | 193 | 31 | 3 | 58e94fe2e89cdafc6974938f97a4c162061a437d | |
| ToppCell | COVID-19-lung-CD8+_T_cells|lung / Disease (COVID-19 only), tissue and cell type | 3.20e-04 | 193 | 31 | 3 | 780e23e2705fc5c1b70e37568b79731ced5038bd | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-naive_regulatory_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.20e-04 | 193 | 31 | 3 | 28138c35ea82c6b2163f0cae045ca55859347c73 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 3.20e-04 | 193 | 31 | 3 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | background-NK_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 3.20e-04 | 193 | 31 | 3 | f8d6eff1e04926f85d265ec39fe66897fe29574d | |
| Drug | PD173952 | 8.37e-07 | 15 | 29 | 3 | CID005328733 | |
| Drug | PD173956 | 8.37e-07 | 15 | 29 | 3 | CID005330524 | |
| Drug | 6-methoxypurine arabinoside | 3.69e-06 | 24 | 29 | 3 | CID000124757 | |
| Drug | selva | 5.96e-06 | 28 | 29 | 3 | CID000010157 | |
| Drug | 1-methyl-1H-indole-2-carboxylic acid | 9.38e-06 | 4 | 29 | 2 | CID000027695 | |
| Drug | IN1076 | 1.20e-05 | 112 | 29 | 4 | CID000005309 | |
| Drug | Dasatinib | 7.00e-05 | 10 | 29 | 2 | DB01254 | |
| Drug | ponatinib | 8.81e-05 | 68 | 29 | 3 | ctd:C545373 | |
| Drug | dasatinib | 9.60e-05 | 70 | 29 | 3 | CID003062316 | |
| Drug | troglitazone; Down 200; 10uM; PC3; HG-U133A | 1.01e-04 | 193 | 29 | 4 | 431_DN | |
| Drug | N-(2-(3-(3,5-bis(trifluoromethyl)phenyl)ureido)ethyl)glycyrrhetinamide | 1.03e-04 | 12 | 29 | 2 | ctd:C568507 | |
| Drug | Tadjakonine [11087-94-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 1.05e-04 | 195 | 29 | 4 | 4424_UP | |
| Drug | AC1L1J0H | 1.09e-04 | 197 | 29 | 4 | CID000004813 | |
| Drug | AG-028671 [847803-03-6]; Up 200; 10uM; PC3; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 6582_UP | |
| Disease | colorectal cancer (implicated_via_orthology) | 3.40e-06 | 30 | 29 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | intestinal cancer (implicated_via_orthology) | 4.54e-04 | 32 | 29 | 2 | DOID:10155 (implicated_via_orthology) | |
| Disease | kidney disease (implicated_via_orthology) | 7.47e-04 | 41 | 29 | 2 | DOID:557 (implicated_via_orthology) | |
| Disease | intraocular pressure measurement | 1.48e-03 | 509 | 29 | 4 | EFO_0004695 | |
| Disease | basophil measurement | 1.59e-03 | 60 | 29 | 2 | EFO_0803539 | |
| Disease | carcinoma (implicated_via_orthology) | 1.81e-03 | 64 | 29 | 2 | DOID:305 (implicated_via_orthology) | |
| Disease | schizophrenia (is_implicated_in) | 2.67e-03 | 78 | 29 | 2 | DOID:5419 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PLAAPVLCMEYIPEL | 856 | Q9HCE6 | |
| RCPAPYEICPEDYLM | 506 | O60242 | |
| DFMCRIIPNFYPPLE | 436 | Q68E01 | |
| LERPRACPPEVYAIM | 746 | P04629 | |
| FFLCCLREPPPVYPD | 216 | A8MXV4 | |
| PEIVFYELERCLLMP | 321 | Q5HYC2 | |
| MEVCYQLPVLPLDRP | 1 | Q13946 | |
| PELRCIEFPVPKDCY | 416 | A6NHZ5 | |
| MAPPVRYCIPGERLC | 1 | Q9Y3B2 | |
| YCPREHMLPCPLAAL | 936 | O95996 | |
| CPMRNTPEYEELCPR | 996 | P35555 | |
| RGYRMPCPQDCPISL | 481 | P06241 | |
| YDMPRVVACSVEPCP | 156 | Q9NTQ9 | |
| IYCFLRCMEPDPEIP | 281 | Q9NX46 | |
| PFRYRMECPEIDCEE | 131 | P09914 | |
| MEPVFVCQRAPCPYL | 181 | P35212 | |
| RECPMCRSVGPYVPL | 331 | Q96FA3 | |
| DQVERGYRMPCPPEC | 476 | P12931 | |
| GELICPLCMNYFIDP | 11 | P0CI25 | |
| PPCPRLYGVLMEVEE | 586 | Q8N660 | |
| TMCRDYVLDCNILPP | 201 | P52294 | |
| YCPLLFHMDCLEPPL | 291 | Q96QT6 | |
| CSVEIVPRLPDYICP | 16 | Q9BV68 | |
| PRPAACPAEVYVLML | 446 | Q9H3Y6 | |
| KRMECPPECPPELYA | 556 | P43403 | |
| PPECPPELYALMSDC | 561 | P43403 | |
| GELICPLCMNYFIDP | 11 | P0CI26 | |
| DPPLESKYECPICLM | 61 | Q9Y4K3 | |
| VECSFMPCPELACPR | 531 | Q96DN2 | |
| PAPPPTCYMCVERRF | 3111 | Q96JG9 | |
| VYPCPEPAVERREML | 246 | Q9HBG4 | |
| RELICPICMNYFIDP | 11 | A0A3B3IT33 | |
| RELICPICMNYFIDP | 11 | A6NDI0 |